Long-Term Outcomes and Durability of Effect Following Treatment With Cladribine Tablets for MS (CLASSIC-MS)

NCT03961204 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

662

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis (MS)

Interventions

OTHER: Data Collection

Sponsor

EMD Serono Research & Development Institute, Inc.

Collaborators

[object Object]